Biotech news for Thursday, June 11, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Tango Therapeutics ( TNGX ) announced the pricing of an upsized underwritten public offering of 18.17M shares of its common stock and pre-funded warrants to purchase up to 1.83M shares. The gross proceeds from the offering are expected to be approximately $600…
Cellectis ( CLLS ) shares rose in extended trading on Tuesday after the company said that its CD22-targeting allogeneic CAR-T therapy, lasme-cel, received FDA Regenerative Medicine Advanced Therapy (RMAT) designation for a severe form of leukemia. The granting…
Summit Therapeutics ( SMMT ) announced on Tuesday that it has commenced an underwritten public offering of $500M of shares of its common stock. Shares of SMMT slipped over 9% in extended trading on Tuesday. All the shares in the proposed offering
Shattuck Labs ( STTK ) has commenced a public offering of shares of its common stock or, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock. In addition, Shattuck expects to grant
Lakefront Biotherapeutics NV ( LKFT ) announced a share repurchase program of up to €50M. The company may repurchase ordinary shares through December 31, 2026. More on Lakefront Biotherapeutics Lakefront Biotherapeutics NV 2026 Q1 - Results - Earnings Call Pre…
Shares of Novavax ( NVAX ) rose 0.58% to close at $8.67 on Tuesday, ending a six-session slide. The stock has fallen around 18% between June 1 and June 8, compared to a 2.56% decline in the S&P 500 over the same period. According
PM Images Cartesian Therapeutics ( RNAC ) jumped over 30% on Tuesday after announcing a licensing deal to develop its CAR-T cell therapies using a drug delivery technology developed by the mRNA therapeutics company WestGene Biopharma. Under the collaboration,…
Retail investors are rotating out of semiconductor stocks and into higher-beta speculative names, according to recent retail flow data from Vanda Research. The shift comes after months of strong retail buying in semiconductor companies and may reflect investor…
AIM ImmunoTech ( AIM ) on Tuesday said it has entered into definitive agreements for a registered direct offering and concurrent private placement priced at-the-market under NYSE American rules for gross proceeds of approximately $2.65 million. The offering is…
JHVEPhoto/iStock Editorial via Getty Images Disc Medicine ( IRON ) traded higher in the premarket on Tuesday after announcing that the company and the FDA have reached a consensus on a path to receive U.S. approval for its rare disease therapy bitopertin. Earl…